160 related articles for article (PubMed ID: 19945438)
1. Thiopurine S-methyltransferase pharmacogenetics: functional characterization of a novel rapidly degraded variant allozyme.
Feng Q; Vannaprasaht S; Peng Y; Angsuthum S; Avihingsanon Y; Yee VC; Tassaneeyakul W; Weinshilboum RM
Biochem Pharmacol; 2010 Apr; 79(7):1053-61. PubMed ID: 19945438
[TBL] [Abstract][Full Text] [Related]
2. Thiopurine S-methyltransferase pharmacogenetics: chaperone protein association and allozyme degradation.
Wang L; Sullivan W; Toft D; Weinshilboum R
Pharmacogenetics; 2003 Sep; 13(9):555-64. PubMed ID: 12972954
[TBL] [Abstract][Full Text] [Related]
3. Thiopurine S-methyltransferase pharmacogenetics: variant allele functional and comparative genomics.
Salavaggione OE; Wang L; Wiepert M; Yee VC; Weinshilboum RM
Pharmacogenet Genomics; 2005 Nov; 15(11):801-15. PubMed ID: 16220112
[TBL] [Abstract][Full Text] [Related]
4. Thiopurine S-methyltransferase pharmacogenetics: autophagy as a mechanism for variant allozyme degradation.
Li F; Wang L; Burgess RJ; Weinshilboum RM
Pharmacogenet Genomics; 2008 Dec; 18(12):1083-94. PubMed ID: 18820593
[TBL] [Abstract][Full Text] [Related]
5. Human thiopurine S-methyltransferase pharmacogenetics: variant allozyme misfolding and aggresome formation.
Wang L; Nguyen TV; McLaughlin RW; Sikkink LA; Ramirez-Alvarado M; Weinshilboum RM
Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9394-9. PubMed ID: 15967990
[TBL] [Abstract][Full Text] [Related]
6. Enhanced proteasomal degradation of mutant human thiopurine S-methyltransferase (TPMT) in mammalian cells: mechanism for TPMT protein deficiency inherited by TPMT*2, TPMT*3A, TPMT*3B or TPMT*3C.
Tai HL; Fessing MY; Bonten EJ; Yanishevsky Y; d'Azzo A; Krynetski EY; Evans WE
Pharmacogenetics; 1999 Oct; 9(5):641-50. PubMed ID: 10591545
[TBL] [Abstract][Full Text] [Related]
7. Canine red blood cell thiopurine S-methyltransferase: companion animal pharmacogenetics.
Salavaggione OE; Kidd L; Prondzinski JL; Szumlanski CL; Pankratz VS; Wang L; Trepanier L; Weinshilboum RM
Pharmacogenetics; 2002 Dec; 12(9):713-24. PubMed ID: 12464800
[TBL] [Abstract][Full Text] [Related]
8. Cat red blood cell thiopurine S-methyltransferase: companion animal pharmacogenetics.
Salavaggione OE; Yang C; Kidd LB; Thomae BA; Pankratz VS; Trepanier LA; Weinshilboum RM
J Pharmacol Exp Ther; 2004 Feb; 308(2):617-26. PubMed ID: 14610243
[TBL] [Abstract][Full Text] [Related]
9. Aggresome formation and pharmacogenetics: sulfotransferase 1A3 as a model system.
Wang L; Yee VC; Weinshilboum RM
Biochem Biophys Res Commun; 2004 Dec; 325(2):426-33. PubMed ID: 15530410
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of 23 allelic variants of thiopurine S-methyltransferase gene (TPMT*2 - *24).
Ujiie S; Sasaki T; Mizugaki M; Ishikawa M; Hiratsuka M
Pharmacogenet Genomics; 2008 Oct; 18(10):887-93. PubMed ID: 18708949
[TBL] [Abstract][Full Text] [Related]
11. Natriuretic peptide pharmacogenetics: membrane metallo-endopeptidase (MME): common gene sequence variation, functional characterization and degradation.
Pereira NL; Aksoy P; Moon I; Peng Y; Redfield MM; Burnett JC; Wieben ED; Yee VC; Weinshilboum RM
J Mol Cell Cardiol; 2010 Nov; 49(5):864-74. PubMed ID: 20692264
[TBL] [Abstract][Full Text] [Related]
12. Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): mechanisms for the genetic polymorphism of TPMT activity.
Tai HL; Krynetski EY; Schuetz EG; Yanishevski Y; Evans WE
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6444-9. PubMed ID: 9177237
[TBL] [Abstract][Full Text] [Related]
13. Four human thiopurine s-methyltransferase alleles severely affect protein structure and dynamics.
Rutherford K; Daggett V
J Mol Biol; 2008 Jun; 379(4):803-14. PubMed ID: 18482735
[TBL] [Abstract][Full Text] [Related]
14. Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphism.
Szumlanski C; Otterness D; Her C; Lee D; Brandriff B; Kelsell D; Spurr N; Lennard L; Wieben E; Weinshilboum R
DNA Cell Biol; 1996 Jan; 15(1):17-30. PubMed ID: 8561894
[TBL] [Abstract][Full Text] [Related]
15. Identification and functional analysis of two rare allelic variants of the thiopurine S-methyltransferase gene, TPMT*16 and TPMT*19.
Hamdan-Khalil R; Gala JL; Allorge D; Lo-Guidice JM; Horsmans Y; Houdret N; Broly F
Biochem Pharmacol; 2005 Feb; 69(3):525-9. PubMed ID: 15652243
[TBL] [Abstract][Full Text] [Related]
16. Prospects and limits of pharmacogenetics: the thiopurine methyl transferase (TPMT) experience.
van Aken J; Schmedders M; Feuerstein G; Kollek R
Am J Pharmacogenomics; 2003; 3(3):149-55. PubMed ID: 12814323
[TBL] [Abstract][Full Text] [Related]
17. Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyltransferase.
Weinshilboum R
Drug Metab Dispos; 2001 Apr; 29(4 Pt 2):601-5. PubMed ID: 11259360
[TBL] [Abstract][Full Text] [Related]
18. Human thiopurine methyltransferase: molecular cloning and expression of T84 colon carcinoma cell cDNA.
Honchel R; Aksoy IA; Szumlanski C; Wood TC; Otterness DM; Wieben ED; Weinshilboum RM
Mol Pharmacol; 1993 Jun; 43(6):878-87. PubMed ID: 8316220
[TBL] [Abstract][Full Text] [Related]
19. Methylation pharmacogenetics: thiopurine methyltransferase as a model system.
Weinshilboum RM
Xenobiotica; 1992; 22(9-10):1055-71. PubMed ID: 1441597
[TBL] [Abstract][Full Text] [Related]
20. Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozymes.
Szumlanski CL; Honchel R; Scott MC; Weinshilboum RM
Pharmacogenetics; 1992 Aug; 2(4):148-59. PubMed ID: 1306116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
